Medicinal cannabis companies ‘undermined doctor–patient relationship’ Almost $1 million in fines have been issued to companies for unlawfully advertising prescription-only medicinal cannabis products.
TGA flags possible amendments to paracetamol Poisons Standard Wider consultation is being sought on amending current access controls, following a review into the risks of intentional self-poisoning.
Combined flu and COVID-19 tests approved Two separate nasal tests capable of detecting both COVID-19 and influenza have been approved by Australia’s medicines regulator.
Another rapid antigen test sponsor fined by the TGA An Australian company and two of its officers have also been ordered to pay $96,000 for the unlawful importation of surgical face masks.
TGA green lights Nuvaxovid for 12–17-year-olds But while provisional approval has been granted, inclusion in the national program for this age group is yet to be confirmed.
Supply issues flagged as TGA provisionally approves Moderna for under-fives The Federal Health Minister has urged parents to delay booking COVID vaccine appointments for their very young children.
New diabetes medication shortage will impact patient care The semaglutide shortage is having a flow on effect, with dulaglutide now also in short supply until at least the end of August.
Multiple rapid antigen test sponsors under investigation The revelation comes alongside TGA confirmation that a company has been fined more than $100,000 for ‘serial non-compliance’.
Call on COVID vaccine for under-fives likely ‘in coming weeks’ With mRNA vaccines for children aged under-five now approved in US, authorities are actively considering a similar move in Australia.
Novavax receives COVID-19 booster approval The protein-based vaccine is the third to gain TGA approval as a booster in Australia, following Pfizer and Moderna.